{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:10:10Z","timestamp":1783566610386,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100024033","name":"Artificial Intelligence\/Machine Learning Consortium to Advance Health Equity and Researcher Diversity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>NarxCare\u00ae, a proprietary opioid risk scoring system embedded in Prescription Drug Monitoring Programs (PDMPs), has generated significant patient complaints. We adhered to the technical specifications and applied them to PDMP and IQVIA PharMetrics\u00ae Plus Closed Health Plan claims database. Despite adding socioeconomic covariates, precision (0.01\u20130.32) was far below the reported benchmark of 0.75, and F1 scores (0.02\u20130.39) were also substantially lower than the benchmark value of 0.65, across all our reconstructed models.<\/jats:p>","DOI":"10.1038\/s41746-026-02491-y","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:56:34Z","timestamp":1771944994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Algorithmic opacity in opioid risk scoring and the need for transparent AI regulation"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9438-5586","authenticated-orcid":false,"given":"Sherry Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Stofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouzhou","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-382X","authenticated-orcid":false,"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-1729","authenticated-orcid":false,"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2491_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ajhp\/zxaa027","volume":"77","author":"LD Ardeljan","year":"2020","unstructured":"Ardeljan, L. D. et al. Current state of opioid stewardship. Am. J. Health-Syst. Pharm. 77, 636\u2013643 (2020).","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"2491_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-023-02256-0","volume":"29","author":"AM Bhagwat","year":"2023","unstructured":"Bhagwat, A. M., Ferryman, K. S. & Gibbons, J. B. Mitigating algorithmic bias in opioid risk-score modeling to ensure equitable access to pain relief. Nat. Med. 29, 769\u2013770 (2023).","journal-title":"Nat. Med."},{"key":"2491_CR3","unstructured":"Bamboo Health. NarxCare Application Overview, https:\/\/dopl.idaho.gov\/wp-content\/uploads\/2024\/03\/BOP-PDMP-Overview-NarxCare.pdf (2023)."},{"key":"2491_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle, M. R. et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann. Intern. Med. 169, 137\u2013145 (2018).","journal-title":"Ann. Intern. Med."},{"key":"2491_CR5","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman, S. E. et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw. Open 3, e1920622 (2020).","journal-title":"JAMA Netw. Open"},{"key":"2491_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ajad.13051","volume":"29","author":"BE Biondi","year":"2020","unstructured":"Biondi, B. E., Zheng, X., Frank, C. A., Petrakis, I. & Springer, S. A. A literature review examining primary outcomes of medication treatment studies for opioid use disorder: what outcome should be used to measure opioid treatment success? Am. J. Addict. 29, 249\u2013267 (2020).","journal-title":"Am. J. Addict."},{"key":"2491_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/AJP.0000000000001093","volume":"39","author":"M Acharya","year":"2023","unstructured":"Acharya, M. et al. Comparative study of opioid initiation with tramadol, short-acting hydrocodone, or short-acting oxycodone on opioid-related adverse outcomes among chronic noncancer pain patients. Clin. J. pain. 39, 107\u2013118 (2023).","journal-title":"Clin. J. pain."},{"key":"2491_CR8","doi-asserted-by":"publisher","first-page":"103465","DOI":"10.1016\/j.jbi.2020.103465","volume":"107","author":"Z Xu","year":"2020","unstructured":"Xu, Z., Shen, D., Nie, T. & Kou, Y. A hybrid sampling algorithm combining M-SMOTE and ENN based on random forest for medical imbalanced data. J. Biomed. Inform. 107, 103465 (2020).","journal-title":"J. Biomed. Inform."},{"key":"2491_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s11606-023-08528-2","volume":"39","author":"MJ Buonora","year":"2024","unstructured":"Buonora, M. J., Axson, S. A., Cohen, S. M. & Becker, W. C. Paths forward for clinicians amidst the rise of unregulated clinical decision support software: our perspective on NarxCare. J. Gen. Intern. Med. 39, 858\u2013862 (2024).","journal-title":"J. Gen. Intern. Med."},{"key":"2491_CR10","doi-asserted-by":"publisher","first-page":"A16","DOI":"10.1016\/j.annemergmed.2022.04.006","volume":"79","author":"Z Siegel","year":"2022","unstructured":"Siegel, Z. In a World of Stigma and Bias, can a computer algorithm really predict overdose risk?: A machine-learning algorithm is being deployed across America to prevent overdose deaths. but could it be causing more pain?. Ann. Emerg. Med. 79, A16\u2013A19 (2022).","journal-title":"Ann. Emerg. Med."},{"key":"2491_CR11","unstructured":"Szalavitz, M. The pain was unbearable. So why did doctors turn her away. Wired. 11 https:\/\/www.wired.com\/story\/opioid-drug-addiction-algorithm-chronic-pain\/ (2021)."},{"key":"2491_CR12","first-page":"e242691","volume":"5","author":"S Gottlieb","year":"2024","unstructured":"Gottlieb, S. Congress Must Update FDA Regulations for Medical AI. JAMA Forum 5, e242691 (2024).","journal-title":"JAMA Forum"},{"key":"2491_CR13","unstructured":"U.S. Food and Drug Administration. Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. U.S. Department of Health and Human Services. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-decision-support-software (2026)."},{"key":"2491_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.acra.2019.09.017","volume":"27","author":"HB Harvey","year":"2020","unstructured":"Harvey, H. B. & Gowda, V. How the FDA regulates AI. Acad. Radiol. 27, 58\u201361 (2020).","journal-title":"Acad. Radiol."},{"key":"2491_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1017\/amj.2022.3","volume":"47","author":"J Boubker","year":"2021","unstructured":"Boubker, J. When medical devices have a mind of their own: the challenges of regulating artificial intelligence. Am. J. Law Med. 47, 427\u2013454 (2021).","journal-title":"Am. J. Law Med."},{"key":"2491_CR16","doi-asserted-by":"crossref","unstructured":"White House. Winning the AI Race: America\u2019s AI Action Plan, https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2025\/07\/Americas-AI-Action-Plan.pdf (2025).","DOI":"10.2139\/ssrn.5494858"},{"key":"2491_CR17","unstructured":"SimpleMaps. United States ZIP Code Database (Version 2025), https:\/\/simplemaps.com\/data\/us-zip-codes (2025)."},{"key":"2491_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2024.571","volume":"8","author":"C Li","year":"2024","unstructured":"Li, C. et al. Realizing the potential of social determinants data in EHR systems: a scoping review of approaches for screening, linkage, extraction, analysis, and interventions. J. Clin. Transl. Sci. 8, e147 (2024).","journal-title":"J. Clin. Transl. Sci."},{"key":"2491_CR19","doi-asserted-by":"crossref","unstructured":"Hurley, R. W. et al. Evidence-based framework for identifying opioid use disorder in administrative data: a systematic review and methodological development study. Pain Med. 27, 145\u2013159 (2025).","DOI":"10.1093\/pm\/pnaf116"},{"key":"2491_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/ADM.0000000000001330","volume":"18","author":"KS Elkington","year":"2024","unstructured":"Elkington, K. S. et al. Examining the impact of the innovative opioid court model on treatment access and court outcomes for court participants. J. Addict. Med. 18, 635\u2013642 (2024).","journal-title":"J. Addict. Med."},{"key":"2491_CR21","doi-asserted-by":"publisher","unstructured":"Roy P.J. et al. Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder. https:\/\/doi.org\/10.1111\/add.70288 (2025).","DOI":"10.1111\/add.70288"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02491-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:23:43Z","timestamp":1777415023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02491-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2491"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02491-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7368491\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-7368491\/v2","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}